1-(4-methoxyphenyl)cyclohexanecarbaldehyde | 56140-77-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-methoxyphenyl)cyclohexanecarbaldehyde
• 英文别名: 1-(4-Methoxyphenyl)cyclohexane-1-carbaldehyde
• CAS: 56140-77-3
• 化学式: C₁₄H₁₈O₂
• 分子量: 218.296
• InChiKey: ZTNQFCXKIXMBLZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-(cyclohexylidenemethyl)-4-methoxybenzene 在 碘 、 mercury(II) oxide 作用下， 生成 1-(4-methoxyphenyl)cyclohexanecarbaldehyde
  参考文献：
  名称：

  Tiffeneau et al., Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1935, vol. 201, p. 277

  摘要：

  DOI：

文献信息

• Controlled Reduction of Nitriles by Sodium Hydride and Zinc Chloride
  作者：Shunsuke Chiba、Derek Yiren Ong

  DOI：10.1055/s-0039-1690838

  日期：2020.5

  new protocol for the controlled reduction of nitriles to aldehydes was developed using a combination of sodium hydride and zinc chloride. The iminyl zinc intermediates derived from aromatic nitriles could be further functionalized with allylmetal nucleophiles to afford homoallylamines. As the method allows the reduction of various aliphatic and aromatic nitriles with a concise procedure under milder

  使用氢化钠和氯化锌的组合，开发了一种控制腈还原为醛的新方案。衍生自芳族腈的亚胺基锌中间体可以用烯丙基金属亲核试剂进一步官能化以提供高烯丙基胺。由于该方法可以在较温和的反应条件下以简明的方法还原各种脂族和芳族腈，并且具有广泛的官能团相容性，因此非常适合用于化学合成中的各种机会。
• Hydride Reduction by a Sodium Hydride-Iodide Composite
  作者：Pei Chui Too、Guo Hao Chan、Ya Lin Tnay、Hajime Hirao、Shunsuke Chiba

  DOI：10.1002/anie.201600305

  日期：2016.3.7

  Sodium hydride (NaH) is widely used as a Brønsted base in chemical synthesis and reacts with various Brønsted acids, whereas it rarely behaves as a reducing reagent through delivery of the hydride to polar π electrophiles. This study presents a series of reduction reactions of nitriles, amides, and imines as enabled by NaH in the presence of LiI or NaI. This remarkably simple protocol endows NaH with

  氢化钠（NaH）在化学合成中被广泛用作布朗斯台德碱，并与各种布朗斯台德酸发生反应，而它几乎不通过将氢化物传递给极性π亲电试剂来充当还原剂。这项研究提出了在LiI或NaI存在下，NaH使腈，酰胺和亚胺发生的一系列还原反应。这种非常简单的方案使NaH具有前所未有的独特的氢化物-给体化学反应性。
• An Improved Protocol for the Pd-Catalyzed α-Arylation of Aldehydes with Aryl Halides
  作者：Rubén Martín、Stephen L. Buchwald

  DOI：10.1021/ol8017775

  日期：2008.10.16

  An improved protocol for the Pd-catalyzed alpha-arylation of aldehydes with aryl halides has been developed. The new catalytic system allows for the coupling of an array of substrates including challenging electron-rich aryl bromides and less reactive aryl chlorides. The utility of this method has been demonstrated in a new total synthesis of (+/-)-sporochnol.

  已经开发出用于钯与芳基卤化物的醛催化的α-芳基化的改进方案。新的催化系统允许偶联一系列底物，包括具有挑战性的富电子的芳基溴化物和反应性较低的芳基氯化物。该方法的实用性已在新的（+/-）-亚砜醇的全合成中得到证明。
• α‐Arylation, α‐Arylative Esterification, or Acylation: A Stoichiometry‐Dependent Trichotomy in the Pd‐Catalyzed Cross‐Coupling between Aldehydes and Aryl Bromides
  作者：Pradeep Nareddy、Clément Mazet

  DOI：10.1002/asia.201300724

  日期：2013.11

  Three′s company: The selective α‐arylation and α‐arylative esterification of linear and branched aldehydes is reported for a variety of bromoarenes. The acylation of aryl bromides can be achieved with linear aldehydes (see scheme). All these transformations were performed with a single [(N‐heterocyclic carbene)Pd] catalyst through adjustment of the stoichiometry of the reagents and the appropriate

  Three's company：报道了各种溴代芳烃对直链和支链醛的选择性α-芳基化和α-芳基酯化反应。芳基溴化物的酰化可通过线性醛来实现（参见方案）。所有这些转化都是通过调整试剂的化学计量和适当的碱，使用单一的[（N-杂环卡宾）Pd]催化剂进行的。
• EP300/CREBBP INHIBITOR
  申请人：Daiichi Sankyo Co., Ltd.

  公开号：EP3643703A1

  公开（公告）日：2020-04-29

  The present invention provides a compound having excellent histone acetyltransferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein ring Q1, ring Q2, R1, R2, R3 and R4 respectively have the same meanings as defined in the specification.

  本发明提供了一种对 EP300 和/或 CREBBP 具有优异组蛋白乙酰转移酶抑制活性的化合物或其药理学上可接受的盐。该化合物由下式（1）或其药理学上可接受的盐表示： 其中，环 Q1、环 Q2、R1、R2、R3 和 R4 分别具有本说明书中定义的相同含义。